Table of Content

Table of Contents

Global RNA Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 siRNA -Product Introduction and Major Manufacturers
1.1.2 ASO -Product Introduction and Major Manufacturers
1.1.3 miRNA -Product Introduction and Major Manufacturers
1.1.4 Nucleic Acid Aptamers -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China RNA Drugs Status and Prospect (2015-2026)
2.1.1 China RNA Drugs Market Size and Growth Rate (2015-2026)
2.1.2 China RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU RNA Drugs Status and Prospect (2015-2026)
2.2.1 EU RNA Drugs Market Size and Growth Rate (2015-2026)
2.2.2 EU RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA RNA Drugs Status and Prospect (2015-2026)
2.3.1 USA RNA Drugs Market Size and Growth Rate (2015-2026)
2.3.2 USA RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan RNA Drugs Status and Prospect (2015-2026)
2.4.1 Japan RNA Drugs Market Size and Growth Rate (2015-2026)
2.4.2 Japan RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India RNA Drugs Status and Prospect (2015-2026)
2.5.1 India RNA Drugs Market Size and Growth Rate (2015-2026)
2.5.2 India RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia RNA Drugs Status and Prospect (2015-2026)
2.6.1 Southeast Asia RNA Drugs Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America RNA Drugs Status and Prospect (2015-2026)
2.7.1 South America RNA Drugs Market Size and Growth Rate (2015-2026)
2.7.2 South America RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 RNA Drugs Status and Prospect (2015-2026)
2.8.1 RNA Drugs Market Size and Growth Rate (2015-2026)
2.8.2 RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global RNA Drugs Market Assessment by Segment
3.1 Global RNA Drugs Capacity and Growth Rate
3.2 Global RNA Drugs Sales by Type
3.3 Global RNA Drugs Sales Revenue by Type
3.4 Global RNA Drugs Consumption by Application
4 Global RNA Drugs Market Assessment by Regions
4.1 Global RNA Drugs Production Analysis and Forecast by Regions (2015-2026)
4.2 Global RNA Drugs Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global RNA Drugs Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 RNA Drugs Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on RNA Drugs Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global RNA Drugs Capacity Market Share of Manufacturers (2019-2020)
6.2 Global RNA Drugs Sales Market Share of Manufacturers (2019-2020)
6.3 Global RNA Drugs Sales Revenue Market Share of Manufacturers (2019-2020)

7 RNA Drugs Competitive Analysis
7.1 Pfizer
7.1.1 Pfizer Company Profiles
7.1.2 Pfizer Product Introduction
7.1.3 Pfizer RNA Drugs Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Roche
7.2.1 Roche Company Profiles
7.2.2 Roche Product Introduction
7.2.3 Roche RNA Drugs Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Profiles
7.3.2 Sanofi-Aventis Product Introduction
7.3.3 Sanofi-Aventis RNA Drugs Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Profiles
7.4.2 Abbott Laboratories Product Introduction
7.4.3 Abbott Laboratories RNA Drugs Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Arrowhead Pharmaceuticals
7.5.1 Arrowhead Pharmaceuticals Company Profiles
7.5.2 Arrowhead Pharmaceuticals Product Introduction
7.5.3 Arrowhead Pharmaceuticals RNA Drugs Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Benitec Biopharma
7.6.1 Benitec Biopharma Company Profiles
7.6.2 Benitec Biopharma Product Introduction
7.6.3 Benitec Biopharma RNA Drugs Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Calimmune Inc
7.7.1 Calimmune Inc Company Profiles
7.7.2 Calimmune Inc Product Introduction
7.7.3 Calimmune Inc RNA Drugs Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Dicerna
7.8.1 Dicerna Company Profiles
7.8.2 Dicerna Product Introduction
7.8.3 Dicerna RNA Drugs Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Gradalis
7.9.1 Gradalis Company Profiles
7.9.2 Gradalis Product Introduction
7.9.3 Gradalis RNA Drugs Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Quark
7.10.1 Quark Company Profiles
7.10.2 Quark Product Introduction
7.10.3 Quark RNA Drugs Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 RXi
7.12 Senesco
7.13 Silence Therapeutics
7.14 Silenseed
7.15 Tekmira
7.16 Alnylam Pharmaceuticals
8 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global RNA Drugs Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global RNA Drugs Sales (K Unit) by Type (2015-2026)
Figure Global RNA Drugs Sales (K Unit) and Growth Rate (2015-2026)
Figure Global RNA Drugs Sales Market Share (%) by Type (2019 -2020)
Table Global RNA Drugs Sales Value (Million USD) by Type (2015-2026)
Figure Global RNA Drugs Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global RNA Drugs Sales Value Market Share (%) by Type (2019-2020)
Table Global RNA Drugs Sales (K Unit) by Application (2015-2026)
Figure China RNA Drugs Production Value (Million USD) and Growth Rate (2015-2026)
Table China RNA Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU RNA Drugs Production Value (Million USD) and Growth Rate (2015-2026)
Table EU RNA Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America RNA Drugs Production Value (Million USD) and Growth Rate (2015-2026)
Table North America RNA Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan RNA Drugs Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan RNA Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India RNA Drugs Production Value (Million USD) and Growth Rate (2015-2026)
Table India RNA Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia RNA Drugs Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia RNA Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America RNA Drugs Production Value (Million USD) and Growth Rate (2015-2026)
Table South America RNA Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa RNA Drugs Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa RNA Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global RNA Drugs Capacity (K Units) and Growth Rate (2015-2026)
Figure Global RNA Drugs Capacity (K Units) and Growth Rate (2015-2026)
Table Global RNA Drugs Sales (Unit) by Type (2015-2026)
Figure Global RNA Drugs Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global RNA Drugs Sales Revenue (Million USD) by Type (2015-2026)
Figure Global RNA Drugs Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global RNA Drugs Consumption (Unit) by Application (2015-2026)
Figure Global RNA Drugs Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global RNA Drugs Production (K Unite) by Regions (2015-2020)
Table Global RNA Drugs CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global RNA Drugs Production Share by Regions (2019-2020)
Table Global RNA Drugs Sales (K Unite) by Regions (2015-2020)
Table Global RNA Drugs CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global RNA Drugs Sales Share by Regions (2019-2020)
Table Global RNA Drugs Sales Revenue (Million USD) by Regions (2015-2020)
Table Global RNA Drugs CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global RNA Drugs Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of RNA Drugs
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of RNA Drugs
Figure Cost Structure of RNA Drugs in 2020
Table Global RNA Drugs Capacity Share of Manufacturers (2019-2020)
Figure Global RNA Drugs Capacity Share of Manufacturers (2019-2020)
Table Global RNA Drugs Sales Market Share of Manufacturers (2019-2020)
Figure Global RNA Drugs Sales Market Share of Manufacturers (2019-2020)
Table Global RNA Drugs Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global RNA Drugs Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global RNA Drugs Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ????Pfizer Profiles
Table ????Pfizer RNA Drugs Product Introduction
Table ????Pfizer RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Pfizer SWOT Analysis
Table ????Roche Profiles
Table ????Roche RNA Drugs Product Introduction
Table ????Roche RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Roche SWOT Analysis
Table ????Sanofi-Aventis Profiles
Table ????Sanofi-Aventis RNA Drugs Product Introduction
Table ????Sanofi-Aventis RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Sanofi-Aventis SWOT Analysis
Table ????Abbott Laboratories Profiles
Table ????Abbott Laboratories RNA Drugs Product Introduction
Table ????Abbott Laboratories RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Abbott Laboratories SWOT Analysis
Table ????Arrowhead Pharmaceuticals Profiles
Table ????Arrowhead Pharmaceuticals RNA Drugs Product Introduction
Table ????Arrowhead Pharmaceuticals RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Arrowhead Pharmaceuticals SWOT Analysis
Table ????Benitec Biopharma Profiles
Table ????Benitec Biopharma RNA Drugs Product Introduction
Table ????Benitec Biopharma RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Benitec Biopharma SWOT Analysis
Table ????Calimmune Inc Profiles
Table ????Calimmune Inc RNA Drugs Product Introduction
Table ????Calimmune Inc RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Calimmune Inc SWOT Analysis
Table ????Dicerna Profiles
Table ????Dicerna RNA Drugs Product Introduction
Table ????Dicerna RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Dicerna SWOT Analysis
Table ????Gradalis Profiles
Table ????Gradalis RNA Drugs Product Introduction
Table ????Gradalis RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Gradalis SWOT Analysis
Table ????Quark Profiles
Table ????Quark RNA Drugs Product Introduction
Table ????Quark RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Quark SWOT Analysis
Table ????RXi Profiles
Table ????RXi RNA Drugs Product Introduction
Table ????RXi RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????RXi SWOT Analysis
Table ????Senesco Profiles
Table ????Senesco RNA Drugs Product Introduction
Table ????Senesco RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Senesco SWOT Analysis
Table ????Silence Therapeutics Profiles
Table ????Silence Therapeutics RNA Drugs Product Introduction
Table ????Silence Therapeutics RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Silence Therapeutics SWOT Analysis
Table ????Silenseed Profiles
Table ????Silenseed RNA Drugs Product Introduction
Table ????Silenseed RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Silenseed SWOT Analysis
Table ????Tekmira Profiles
Table ????Tekmira RNA Drugs Product Introduction
Table ????Tekmira RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Tekmira SWOT Analysis
Table ????Alnylam Pharmaceuticals Profiles
Table ????Alnylam Pharmaceuticals RNA Drugs Product Introduction
Table ????Alnylam Pharmaceuticals RNA Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Alnylam Pharmaceuticals SWOT Analysis